Yesterday, on May 14, the Saeima passed the Biobank Law, marking a historic turning point for Latvian science. This legislation finally organizes the legal framework for the use of human biological materials in research. For the Latvian Biomedical Research and Study Centre (BMC)—home to the largest and most advanced biobank, the Latvian National Biobank—this law translates to increased operational efficiency and expanded opportunities for international cooperation.
“The Biobank Law is the foundation for the development of science and personalized medicine. It creates a stable and modern basis for conducting research of high scientific excellence in Latvia, promotes the development of internationally competitive biomedical research, and strengthens Latvia’s capabilities in the field of personalized medicine. The regulation of the biobanking sector will foster sustainable biobank development, the safe and responsible use of biological samples and data in research, and open new opportunities for innovation, patient treatment, and the improvement of public health,” emphasizes Vita Rovīte, Head of the Latvian National Biobank and Senior Researcher at BMC.
What does the new regulation mean for BMC and our researchers?
The law defines a uniform set of “rules of the game” for all biobanks, which is essential for BMC in its role as the national coordinator in this field:
- Clearer Informed Consent: It will be easier for scientists to communicate with the public, ensuring that donated samples serve public health while strictly protecting personal privacy and data security.
- Development of Precision Medicine: BMC researchers will be able to develop personalized treatment methods more purposefully. The law facilitates the accessibility of data and samples, which is critical for research in oncology, rare diseases, and cardiology.
- International Competitiveness: Organized legislation allows BMC to integrate more fully into European biobank networks (such as BBMRI-ERIC), attracting foreign investment and prestigious international projects.
- Ethical and Quality Standards: The law reinforces the highest ethical requirements, which have always been a priority for BMC and are now becoming the mandatory standard for the entire industry.
https://www.vm.gov.lv/lv/jaunums/saeima-pienem-biobanku-likumu-stiprina-pamatus-precizijas-medicinas-attistibai